Skip to main content
. 2022 Jul 15;77(4):1287–1302. doi: 10.1002/hep.32631

FIGURE 1.

FIGURE 1

Plasma and hepatic apolipoprotein F (APOF) expression are negatively correlated with steatosis and dyslipidemia in a cohort of patients with obesity. (A) Normalized hepatic APOF messenger NA expression (left) and plasma APOF label free quantification (LFQ) intensity (right) in relation with stage of steatosis in patients with obesity. Relationship of plasma triglyceride (TG) (B), non–high‐density lipoprotein (HDL)‐C (C), and HDL‐C (D) with hepatic APOF expression (left) and plasma APOF intensity (right) in a cohort of patients with obesity (n = 551 for transcriptomes; 128 men and 423 women and n = 435 for plasma protein; 101 men and 334 women). Data from (A) are shown as the log2 fold change compared to grade 0 ± SEM.